Ireland’s corporate tax revenue is poised for a record high, with preliminary figures indicating a substantial increase driven by a concentration of receipts from a small number of US multinational corporations. The surge comes despite growing concerns about the country’s over-reliance on these revenues and potential vulnerabilities linked to shifts in US economic and fiscal policy.
Data released this week shows foreign multinationals paid a record 88% of all Irish corporate tax last year, with the largest 10 firms accounting for 57% of the total. This trend underscores the significant dependence of the Irish economy on a relatively small group of companies, particularly those based in the United States. The Irish Fiscal Advisory Council (Ifac) has repeatedly warned about this concentration, highlighting the risks associated with such a narrow tax base.
The State’s financial watchdog estimated last week that three American multinationals – Apple, Microsoft, and Eli Lilly – pay one out of every €10 of tax collected in Ireland. Their corporation taxes alone cover the entire national schools bill. This dependence has deepened since Ireland ended the “Double Irish” tax planning strategy in 2020, prompting US firms with historical ties to the country to shift intellectual property (IP) to Ireland and the US to grab advantage of available tax incentives. This shift coincided with a significant increase in Irish corporate tax revenue, particularly for firms that are less capital-intensive.
However, the continued reliance on these revenues is not without risk. The International Monetary Fund (IMF) has cautioned that a potential collapse in tech company share prices could have “broader implications for macro financial stability” if the anticipated productivity gains from artificial intelligence do not materialize. Ifac has echoed these concerns, noting that the range of possible outcomes for future tech sector profits – and the corporation tax they pay – is “exceptionally wide and highly uncertain.”
The situation is further complicated by evolving US policies. While some recent changes, such as those introduced during the Trump administration, may have temporarily boosted Ireland’s corporation tax receipts, these benefits could be short-lived. The US is actively pursuing policies aimed at encouraging domestic manufacturing and lowering domestic drug prices, both of which could reduce the amount of corporation tax paid in Ireland.
Despite these warnings, sectors like pharmaceuticals – particularly those producing blockbuster weight-loss and diabetes treatments – and the tech sector, driven by advances in artificial intelligence, are expected to sustain or even increase tax revenue. The introduction of a global minimum corporate tax rate of 15% for large companies, scheduled to take effect from mid-2026, is also expected to generate additional revenue and provide some stability to Ireland’s public finances.
Brian Cronin, author of a recent Fiscal Council report, warned that the temporary boost to corporation tax receipts from recent US policy changes could quickly reverse. The report highlighted the vulnerability of Ireland’s economy to shifts in US fiscal and trade policies, given that approximately three-quarters of corporation tax is paid by major US multinationals.
